LZ1 peptide
Description
LZ1 peptide is a pyruvate kinase inhibitor, antimicrobial agent, and antimalarial agent. LZ1 peptide reduces ATP production and inhibits Plasmodium falciparum. LZ1 peptide is active against Plasmodium berghei in mice, reducing parasitemia. LZ1 peptide shows good antimicrobial activity against pathogens associated with acne vulgaris. LZ1 peptide has anti-inflammatory effects. LZ1 peptide can be used in malaria-related research.
Product Details
| Product Name | LZ1 peptide |
| Biological activity | LZ1 peptide acts as a Pyruvate kinase inhibitor, antimicrobial agent, and antimalarial agent. LZ1 peptide reduces ATP production and inhibits the malaria parasite Plasmodium falciparum. LZ1 peptide exhibits activity against Plasmodium berghei in mice and reduces parasitemia. LZ1 peptide shows favorable antimicrobial activity against pathogens associated with acne vulgaris. LZ1 peptide possesses anti-inflammatory effects. LZ1 peptide can be used in malaria-related research. |
| Molecular Weight | 2227.75 |
| Formula | C113H167N33O15 |
| CAS Number | 1423743-97-8 |
| Sequence | Val-Lys-Arg-Trp-Lys-Lys-Trp-Trp-Arg-Lys-Trp-Lys-Lys-Trp-Val-NH2 |
| Sequence Shortening | VKRWKKWWRKWKKWV-NH2 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
